Cargando…
Novel agents for anti-platelet therapy
Anti-platelet therapy plays an important role in the treatment of patients with thrombotic diseases. The most commonly used anti-platelet drugs, namely, aspirin, ticlopidine, and clopidogrel, are effective in the prevention and treatment of cardio-cerebrovascular diseases. Glycoprotein IIb/IIIa anta...
Autores principales: | Ji, Xuebin, Hou, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224753/ https://www.ncbi.nlm.nih.gov/pubmed/22053759 http://dx.doi.org/10.1186/1756-8722-4-44 |
Ejemplares similares
-
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies
por: Xu, Xiaohong Ruby, et al.
Publicado: (2016) -
Anti-platelet agents in pediatric cardiac practice
por: Mohanty, Sweta, et al.
Publicado: (2013) -
Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy
por: Wolska, Nina, et al.
Publicado: (2019) -
Molecular Drivers of Platelet Activation: Unraveling Novel Targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory Therapy
por: Chatterjee, Madhumita, et al.
Publicado: (2020) -
Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery
por: Ho, H. H., et al.
Publicado: (2010)